UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Sound Income Strategies LLC

Sound Income Strategies LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,891 shares of the healthcare conglomerate’s stock after buying an additional 448 shares during the period. Sound Income Strategies LLC’s holdings in UnitedHealth Group were worth $935,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Paralel Advisors LLC increased its stake in UnitedHealth Group by 1.1% in the third quarter. Paralel Advisors LLC now owns 4,047 shares of the healthcare conglomerate’s stock valued at $2,040,000 after acquiring an additional 44 shares during the period. Primecap Management Co. CA boosted its holdings in UnitedHealth Group by 4.9% during the third quarter. Primecap Management Co. CA now owns 20,014 shares of the healthcare conglomerate’s stock worth $10,091,000 after purchasing an additional 930 shares during the last quarter. Milestone Asset Management LLC boosted its holdings in UnitedHealth Group by 17.5% during the third quarter. Milestone Asset Management LLC now owns 516 shares of the healthcare conglomerate’s stock worth $266,000 after purchasing an additional 77 shares during the last quarter. Westfield Capital Management Co. LP increased its position in UnitedHealth Group by 1.2% during the third quarter. Westfield Capital Management Co. LP now owns 430,802 shares of the healthcare conglomerate’s stock worth $217,206,000 after acquiring an additional 5,095 shares during the period. Finally, Weik Capital Management increased its holdings in UnitedHealth Group by 0.6% in the 3rd quarter. Weik Capital Management now owns 10,427 shares of the healthcare conglomerate’s stock valued at $5,257,000 after buying an additional 61 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $5.38 on Tuesday, hitting $484.60. 3,209,678 shares of the company were exchanged, compared to its average volume of 4,167,338. The stock’s 50 day moving average price is $498.20 and its 200 day moving average price is $502.75. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $446.02 billion, a P/E ratio of 29.62, a price-to-earnings-growth ratio of 1.40 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.26 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be issued a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.73%. The ex-dividend date is Monday, June 17th. UnitedHealth Group’s payout ratio is 51.34%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Bank of America reissued a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Robert W. Baird started coverage on shares of UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price on the stock. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, June 20th. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, Barclays boosted their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.